💊 ยา A-Z 🧬 เป้าหมาย 🛠 เครื่องมือ 📚 คู่มือ
ยาทั้งหมด หมวดหมู่ยา ด้านการรักษา ผลข้างเคียง
คู่มือ อภิธานศัพท์ ไทม์ไลน์
การเปรียบเทียบ เส้นทางของยา กลุ่มยา
🇺🇸 English 🇰🇷 한국어 🇯🇵 日本語 🇨🇳 中文简体 🇪🇸 Español 🇧🇷 Português 🇮🇳 हिन्दी 🇸🇦 العربية 🇫🇷 Français 🇷🇺 Русский 🇩🇪 Deutsch 🇹🇷 Türkçe 🇻🇳 Tiếng Việt 🇮🇩 Bahasa Indonesia 🇹🇭 ไทย

Sodium Pertechnetate

CHEMBL2110571 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
—
Bioavailability
—
Protein Binding
—
Molecular Weight
183.9 g/mol
LogP
—
Phase
4

Sodium pertechnetate is an inorganic technetium salt used as a general-purpose radiopharmaceutical precursor and diagnostic imaging agent for thyroid scintigraphy, Meckel's diverticulum scanning, and radionuclide ventriculography in prostate cancer and rheumatoid arthritis assessment. As the pertechnetate anion (TcO4-), it is a chemical analog of iodide and is concentrated by the thyroid gland and gastric mucosa via the sodium-iodide symporter. It is the primary precursor for labeling other technetium-99m radiopharmaceuticals.

น้ำหนักโมเลกุล

183.8940 g/mol

TPSA

74.30 Ų

ด้านการรักษา

Thyroid Cancer Rheumatoid Arthritis Prostate Cancer

กลไกการออกฤทธิ์

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

SMILES

[O-][Tc](=O)(=O)=O.[Na+]

InChI

InChI=1S/Na.4O.Tc/q+1;;;;-1;

Molecular Formula

NaO4Tc

HBD / HBA

- / 4

พันธะที่หมุนได้

0

อะตอมหนัก

6

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Sodium pertechnetate is an inorganic technetium salt used as a general-purpose radiopharmaceutical precursor and diagnostic imaging agent for thyroid scintigraphy, Meckel's diverticulum scanning, and radionuclide ventriculography in prostate cancer and rheumatoid arthritis assessment. As the pertechnetate anion (TcO4-), it is a chemical analog of iodide and is concentrated by the thyroid gland and gastric mucosa via the sodium-iodide symporter. It is the primary precursor for labeling other technetium-99m radiopharmaceuticals.

Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.

Yes, Sodium Pertechnetate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL2110571. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 74086836. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.